Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: Affect Sci. 2020 Nov 30;2(2):112–127. doi: 10.1007/s42761-020-00021-x

Fig 1:

Fig 1:

Procedure overview for single study session. Light blue bars denote participants rating their current anxiety level and anticipated pain for upcoming stimulations. Pre-priming stimulations (B) were administered to skin sites 1–4 (purple) whereas post-priming trials (D) were administered to skin sites 5–8 (yellow).